Back to Search Start Over

The N⁶-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity

Authors :
70878347
60570140
10379092
Yoshinaga, Masanori
Han, Kyuho
Morgens, David W.
Horii, Takuro
Kobayashi, Ryosuke
Tsuruyama, Tatsuaki
Hia, Fabian
Yasukura, Shota
Kajiya, Asako
Cai, Ting
Cruz, Pedro H. C.
Vandenbon, Alexis
Suzuki, Yutaka
Kawahara, Yukio
Hatada, Izuho
Bassik, Michael C.
Takeuchi, Osamu
70878347
60570140
10379092
Yoshinaga, Masanori
Han, Kyuho
Morgens, David W.
Horii, Takuro
Kobayashi, Ryosuke
Tsuruyama, Tatsuaki
Hia, Fabian
Yasukura, Shota
Kajiya, Asako
Cai, Ting
Cruz, Pedro H. C.
Vandenbon, Alexis
Suzuki, Yutaka
Kawahara, Yukio
Hatada, Izuho
Bassik, Michael C.
Takeuchi, Osamu
Publication Year :
2022

Abstract

During erythroid differentiation, the maintenance of genome integrity is key for the success of multiple rounds of cell division. However, molecular mechanisms coordinating the expression of DNA repair machinery in erythroid progenitors are poorly understood. Here, we discover that an RNA N⁶-methyladenosine (m⁶A) methyltransferase, METTL16, plays an essential role in proper erythropoiesis by safeguarding genome integrity via the control of DNA-repair-related genes. METTL16-deficient erythroblasts exhibit defective differentiation capacity, DNA damage and activation of the apoptotic program. Mechanistically, METTL16 controls m⁶A deposition at the structured motifs in DNA-repair-related transcripts including Brca2 and Fancm mRNAs, thereby upregulating their expression. Furthermore, a pairwise CRISPRi screen revealed that the MTR4-nuclear RNA exosome complex is involved in the regulation of METTL16 substrate mRNAs in erythroblasts. Collectively, our study uncovers that METTL16 and the MTR4-nuclear RNA exosome act as essential regulatory machinery to maintain genome integrity and erythropoiesis.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1458642349
Document Type :
Electronic Resource